Search

everythinglearnresearchcommunity

for

Search:↓

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Bridging anticoagulation may raise post-surgery bleeding risks.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Some drugs can cause changes to your hair.

A rare adrenal gland tumor can cause unusual symptoms due to hormone changes.

The AI model somewhat predicts lymph node status in melanoma patients using skin sample images.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Stress increases neurosteroids that help prevent seizures.

MK-5108 is safe and shows potential against tumors, especially alone.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Betulinic acid can help treat hepatitis C by stopping virus replication.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.